Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis | Zendy

Wei Fang | Zendy; Dimitrios G. Oreopoulos | Zendy; Joanne M. Bargman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis

Author(s) -

Wei Fang,

Dimitrios G. Oreopoulos,

Joanne M. Bargman

Publication year - 2008

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfn321

Subject(s) - medicine , peritoneal dialysis , angiotensin receptor blockers , angiotensin converting enzyme , ace inhibitor , dialysis , hemodialysis , chronic renal failure , urology , pharmacology , endocrinology , blood pressure

Angiotensin-converting enzyme (ACE) inhibitors have been shown to improve outcome in patients with renal failure not on dialysis therapy and patients on haemodialysis (HD). However, their effect on survival has not been studied in peritoneal dialysis (PD) patients. The present study examined the association between therapy with ACE inhibitor/ARB and mortality in patients undergoing chronic PD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research